Eimunjeze replaces Adeyeye as DG of NAFDAC
Dr Monica Eimunjeze has replaced Prof. Moji Adeyeye as the new Director General of the National Agency for Food Drugs Administration and Control (NAFDAC), though in an acting capacity.
Prof. Adeyeye’s five-year tenure as Director General of the agency had elapsed on November 2, as President Muhammadu Buhari failed to renew it, prompting the appointment of a replacement in Eimunjeze.
President Buhari appointed Adeyeye as the NAFDAC DG in November 2017 for a five-year renewable term.
However, an internal distributed by the Director of Human Resources Management, A. U. Oboli, to units and departments in NAFDAC informed of Adeyeye’s replacement.
The communication with reference number NAFDAC/ADM/SM/075 was addressed to the directors.
Oboli disclosed that the government had appointed Dr Monica Eimunjeze as the Acting Director-General with effect from November 12.
“I am therefore directed to bring this development to you for information and guidance,” she added.
The new head of the agency studied Pharmacy at Ahmadu Bello University (ABU) Zaria and graduated in 1986.
She obtained a Doctor of Pharmacy degree from Mercer University in Atlanta, and a Master of Science (MSc) in Biotechnology, Innovation and Regulatory Science from Purdue University.
Eimunjeze has years of experience in the pharmaceutical sector. She had her industrial exposure with GlaxoSmithKline from 1989 to 1996.
She was previously NAFDAC Director of Registration and Regulatory Affairs, Director of Drug Evaluation and Research, as well as Technical Assistant to the DG.
Meanwhile, in a related development, the Director of Public Affairs of the agency, Dr Jimoh Abubakar, has disclosed of a planned meeting between the new Acting DG with the Management staff of NAFDAC ‘to disclose her areas of focus.’
Abubakar said that the NAFDAC acting D-G would also seek the support of the directors to excel in her new task of piloting the agency’s affairs.
“The new D-G wants to hit the ground running, this is why she has decided to convene a meeting with directors of the agency on Tuesday, November 22.
“She wants to touch on what will be the focus of her administration, using the SWOT analysis and move in quick succession.
“What I mean by SWOT analysis is for her to look at the Strength, Weaknesses, Opportunities and Threats for the agency.
“The meeting will also be looking at gap analysis, this is the process companies use to compare their current performance with their desired, expected performance and look whether we are meeting our expectations.
“All these will be geared toward improving the system,” Abubakar said.